Clinical Innovations, LLC acquires technologies from Glenveigh Medical
Glenveigh Medical has pioneered innovative products for addressing critical obstetric clinical needs, such as postpartum hemorrhage. In particular, the ebb complete tamponade system offers significant advancements over the current standard of care. “Clinical Innovations’ focused labor & delivery sales and marketing channel will help ensure more physicians and patients have access to this life-saving device,” said Shacey Petrovic, president and CEO of CI. “We are committed to developing technologies that assist our customers in improving obstetric management, safety and outcomes, and the addition of these products to our market-leading portfolio will help us achieve this mission.”
“Postpartum hemorrhage is the most preventable cause of maternal morbidity and mortality worldwide, and it is on the rise,” said Dr. David Adair, chief scientific officer of Glenveigh Medical. “Improved treatment options, like the dual-balloon feature of ebb, which enables tamponade of both vaginal and uterine bleeding, along with more aggressive treatment protocols, are necessary to improve outcomes associated with postpartum hemorrhage.”
About Clinical Innovations
Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala®Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is a Pritzker Group company. To learn more, visit www.clinicalinnovations.com.Reference: